SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-030273
Filing Date
2023-06-28
Accepted
2023-06-28 08:25:48
Documents
12
Period of Report
2023-06-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 8-K rcus-20230627.htm   iXBRL 8-K 49570
  Complete submission text file 0000950170-23-030273.txt   162351

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rcus-20230627_pre.xml EX-101.PRE 9445
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rcus-20230627.xsd EX-101.SCH 2457
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rcus-20230627_lab.xml EX-101.LAB 12806
6 EXTRACTED XBRL INSTANCE DOCUMENT rcus-20230627_htm.xml XML 4523
Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 (510) 694-6200
Arcus Biosciences, Inc. (Filer) CIK: 0001724521 (see all company filings)

IRS No.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38419 | Film No.: 231049315
SIC: 2834 Pharmaceutical Preparations